|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Stock Screener |
Insider Trading Graph View |
Insider Watch |
Insider Trading - Atara Biotherapeutics Inc. (ATRA)
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2019-02-09 Sale |
2019-02-12 7:18 pm |
Atara Biotherapeutics Inc. | ATRA | Ciechanover Isaac E. CEO |
7,800 | $38.76 | $302,367 | 346,038 (Indirect Direct) |
View |
| 2019-02-11 Sale |
2019-02-11 7:10 pm |
Atara Biotherapeutics Inc. | ATRA | Haqq Christopher EVP, R&D & Chief Scientific Of |
13,975 | $38.55 | $538,736 | 272,718 (Indirect Direct) |
View |
| 2019-02-06 Sale |
2019-02-08 4:28 pm |
Atara Biotherapeutics Inc. | ATRA | Haqq Christopher EVP, R&D & Chief Scientific Of |
12,375 | $38.62 | $477,922 | 286,693 (Indirect Direct) |
View |
| 2019-02-01 Sale |
2019-02-01 6:49 pm |
Atara Biotherapeutics Inc. | ATRA | Newell Joe COO |
1,500 | $38.01 | $57,020 | 69,500 (Direct) |
View |
| 2019-01-23 Sale |
2019-01-25 8:16 pm |
Atara Biotherapeutics Inc. | ATRA | Ciechanover Isaac E. CEO |
7,800 | $35.06 | $273,433 | 433,111 (Direct Indirect) |
View |
| 2019-01-09 Sale |
2019-01-10 6:08 pm |
Atara Biotherapeutics Inc. | ATRA | Ciechanover Isaac E. CEO |
7,800 | $34.55 | $269,470 | 733,285 (Direct Indirect) |
View |
| 2019-01-02 Sale |
2019-01-02 7:51 pm |
Atara Biotherapeutics Inc. | ATRA | Newell Joe COO |
1,500 | $35 | $52,500 | 71,000 (Direct) |
View |
| 2018-12-27 Sale |
2018-12-28 6:51 pm |
Atara Biotherapeutics Inc. | ATRA | Ciechanover Isaac E. CEO |
7,800 | $33.88 | $264,233 | 733,285 (Direct Indirect) |
View |
| 2018-12-12 Sale |
2018-12-13 6:58 pm |
Atara Biotherapeutics Inc. | ATRA | Ciechanover Isaac E. CEO |
7,800 | $42.66 | $332,709 | 733,285 (Direct Indirect) |
View |
| 2018-12-03 Sale |
2018-12-03 7:00 pm |
Atara Biotherapeutics Inc. | ATRA | Newell Joe COO |
1,500 | $41.14 | $61,704 | 72,500 (Direct) |
View |
| 2018-11-28 Sale |
2018-11-29 7:39 pm |
Atara Biotherapeutics Inc. | ATRA | Ciechanover Isaac E. CEO |
7,800 | $40.39 | $315,035 | 733,285 (Direct Indirect) |
View |
| 2018-11-14 Sale |
2018-11-15 7:06 pm |
Atara Biotherapeutics Inc. | ATRA | Ciechanover Isaac E. CEO |
7,800 | $34.62 | $270,052 | 733,285 (Direct Indirect) |
View |
| 2018-11-15 Sale |
2018-11-15 4:53 pm |
Atara Biotherapeutics Inc. | ATRA | Haqq Christopher EVP, R&D & Chief Scientific Of |
775 | $33.81 | $26,203 | 285,580 (Indirect Direct) |
View |
| 2018-11-07 Sale |
2018-11-08 4:08 pm |
Atara Biotherapeutics Inc. | ATRA | MARCUS JOEL S Director |
10,000 | $36.35 | $363,500 | 908,355 (Indirect Direct) |
View |
| 2014-10-21 Purchase(A) |
2018-11-08 4:07 pm |
Atara Biotherapeutics Inc. | ATRA | MARCUS JOEL S Director |
9,090 | $11 | $99,990 | 9,090 (Direct) |
View |
| 2018-11-07 Sale |
2018-11-07 7:44 pm |
Atara Biotherapeutics Inc. | ATRA | Gallagher Carol Giltner Director |
21,374 | $36.38 | $777,586 | 88,818 (Direct) |
View |
| 2018-11-01 Sale |
2018-11-02 8:15 pm |
Atara Biotherapeutics Inc. | ATRA | Newell Joe COO |
1,500 | $35 | $52,500 | 74,000 (Direct) |
View |
| 2018-10-22 Sale |
2018-10-23 6:10 pm |
Atara Biotherapeutics Inc. | ATRA | Ciechanover Isaac E. CEO |
7,800 | $33.95 | $264,796 | 733,285 (Direct Indirect) |
View |
| 2018-10-04 Sale |
2018-10-05 7:45 pm |
Atara Biotherapeutics Inc. | ATRA | Ciechanover Isaac E. CEO |
7,800 | $40.22 | $313,753 | 733,285 (Direct Indirect) |
View |
| 2018-10-01 Sale |
2018-10-02 4:25 pm |
Atara Biotherapeutics Inc. | ATRA | Newell Joe COO |
1,500 | $41.28 | $61,918 | 75,500 (Direct) |
View |
| 2018-09-26 Sale |
2018-09-27 4:56 pm |
Atara Biotherapeutics Inc. | ATRA | Haqq Christopher EVP, R&D & Chief Scientific Of |
13,500 | $43.08 | $581,580 | 286,355 (Indirect Direct) |
View |
| 2018-09-24 Sale |
2018-09-25 5:02 pm |
Atara Biotherapeutics Inc. | ATRA | Haqq Christopher EVP, R&D & Chief Scientific Of |
31,500 | $40.17 | $1,265,330 | 317,286 (Indirect Direct) |
View |
| 2018-09-18 Sale |
2018-09-20 4:26 pm |
Atara Biotherapeutics Inc. | ATRA | Ciechanover Isaac E. CEO |
7,800 | $39.81 | $310,479 | 812,613 (Direct Indirect) |
View |
| 2018-07-27 Purchase |
2018-09-11 6:49 pm |
Atara Biotherapeutics Inc. | ATRA | Koppikar Utpal CFO |
2,000 | $36.8 | $73,600 | 47,000 (Direct) |
View |
| 2018-09-06 Sale |
2018-09-10 4:19 pm |
Atara Biotherapeutics Inc. | ATRA | Ciechanover Isaac E. CEO |
7,800 | $39.35 | $306,923 | 812,613 (Direct Indirect) |
View |
| 2018-09-04 Sale |
2018-09-05 5:28 pm |
Atara Biotherapeutics Inc. | ATRA | Newell Joe COO |
1,500 | $39.45 | $59,178 | 77,000 (Direct) |
View |
| 2018-08-20 Sale |
2018-08-22 4:19 pm |
Atara Biotherapeutics Inc. | ATRA | Ciechanover Isaac E. CEO |
7,800 | $36.36 | $283,647 | 812,613 (Direct Indirect) |
View |
| 2018-08-15 Sale |
2018-08-16 5:12 pm |
Atara Biotherapeutics Inc. | ATRA | Haqq Christopher EVP, R&D & Chief Scientific Of |
775 | $37.54 | $29,094 | 331,355 (Indirect Direct) |
View |
| 2018-08-06 Sale |
2018-08-07 5:56 pm |
Atara Biotherapeutics Inc. | ATRA | Ciechanover Isaac E. CEO |
7,800 | $37.43 | $291,957 | 812,613 (Direct Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2019-02-09 Tax Withholding |
2019-02-12 7:18 pm |
N/A N/A |
Atara Biotherapeutics Inc. | ATRA | Ciechanover Isaac E. CEO |
20,324 | $38.49 | 346,038 (Direct) |
View |
| 2019-02-06 Tax Withholding |
2019-02-12 7:17 pm |
N/A N/A |
Atara Biotherapeutics Inc. | ATRA | Ciechanover Isaac E. CEO |
24,683 | $38.47 | 375,611 (Direct) |
View |
| 2019-02-06 Option Award |
2019-02-08 4:44 pm |
N/A N/A |
Atara Biotherapeutics Inc. | ATRA | Koppikar Utpal CFO |
17,063 | $0 | 64,063 (Direct) |
View |
| 2019-02-06 Option Award |
2019-02-08 4:44 pm |
N/A 2029-02-05 |
Atara Biotherapeutics Inc. | ATRA | Koppikar Utpal CFO |
34,125 | $38.47 | 64,063 (Direct) |
View |
| 2019-02-06 Tax Withholding |
2019-02-08 4:28 pm |
N/A N/A |
Atara Biotherapeutics Inc. | ATRA | Haqq Christopher EVP, R&D & Chief Scientific Of |
1,512 | $38.47 | 286,693 (Direct) |
View |
| 2019-02-06 Option Award |
2019-02-08 4:28 pm |
N/A N/A |
Atara Biotherapeutics Inc. | ATRA | Haqq Christopher EVP, R&D & Chief Scientific Of |
15,000 | $0 | 286,693 (Direct) |
View |
| 2019-02-06 Option Award |
2019-02-08 4:28 pm |
N/A 2029-02-05 |
Atara Biotherapeutics Inc. | ATRA | Haqq Christopher EVP, R&D & Chief Scientific Of |
30,000 | $38.47 | 286,693 (Direct) |
View |
| 2019-02-06 Tax Withholding |
2019-02-08 4:27 pm |
N/A N/A |
Atara Biotherapeutics Inc. | ATRA | Ciechanover Isaac E. CEO |
24,683 | $0 | 375,611 (Direct) |
View |
| 2019-02-06 Option Award |
2019-02-08 4:26 pm |
N/A N/A |
Atara Biotherapeutics Inc. | ATRA | Berger Dietmar Global Head of R&D |
25,000 | $0 | 75,000 (Direct) |
View |
| 2019-02-06 Option Award |
2019-02-08 4:26 pm |
N/A 2029-02-05 |
Atara Biotherapeutics Inc. | ATRA | Berger Dietmar Global Head of R&D |
50,000 | $38.47 | 75,000 (Direct) |
View |
| 2019-02-06 Option Award |
2019-02-08 4:25 pm |
N/A N/A |
Atara Biotherapeutics Inc. | ATRA | Kim Mina VP |
17,063 | $0 | 60,063 (Direct) |
View |
| 2019-02-06 Option Award |
2019-02-08 4:25 pm |
N/A 2029-02-05 |
Atara Biotherapeutics Inc. | ATRA | Kim Mina VP |
34,125 | $38.47 | 60,063 (Direct) |
View |
| 2019-02-06 Tax Withholding |
2019-02-08 4:23 pm |
N/A N/A |
Atara Biotherapeutics Inc. | ATRA | Porter Derrell VP |
1,216 | $38.47 | 24,625 (Direct) |
View |
| 2019-02-06 Option Award |
2019-02-08 4:23 pm |
N/A N/A |
Atara Biotherapeutics Inc. | ATRA | Porter Derrell VP |
12,313 | $0 | 24,625 (Direct) |
View |
| 2019-02-06 Option Award |
2019-02-08 4:23 pm |
N/A 2029-02-05 |
Atara Biotherapeutics Inc. | ATRA | Porter Derrell VP |
24,625 | $38.47 | 24,625 (Direct) |
View |
| 2019-02-06 Tax Withholding |
2019-02-08 4:22 pm |
N/A N/A |
Atara Biotherapeutics Inc. | ATRA | Newell Joe COO |
2,212 | $38.47 | 47,146 (Direct) |
View |
| 2019-02-06 Option Award |
2019-02-08 4:22 pm |
N/A N/A |
Atara Biotherapeutics Inc. | ATRA | Newell Joe COO |
17,500 | $0 | 47,146 (Direct) |
View |
| 2019-02-06 Option Award |
2019-02-08 4:22 pm |
N/A 2029-02-05 |
Atara Biotherapeutics Inc. | ATRA | Newell Joe COO |
35,000 | $38.47 | 47,146 (Direct) |
View |
| 2019-02-01 Exercise |
2019-02-01 6:49 pm |
N/A N/A |
Atara Biotherapeutics Inc. | ATRA | Newell Joe COO |
1,500 | $20.4 | 69,500 (Direct) |
View |
| 2019-02-01 Exercise |
2019-02-01 6:49 pm |
N/A 2024-04-03 |
Atara Biotherapeutics Inc. | ATRA | Newell Joe COO |
1,500 | $20.4 | 69,500 (Direct) |
View |
| 2019-01-02 Exercise |
2019-01-02 7:51 pm |
N/A N/A |
Atara Biotherapeutics Inc. | ATRA | Newell Joe COO |
1,500 | $20.4 | 71,000 (Direct) |
View |
| 2019-01-02 Exercise |
2019-01-02 7:51 pm |
N/A 2024-04-03 |
Atara Biotherapeutics Inc. | ATRA | Newell Joe COO |
1,500 | $20.4 | 71,000 (Direct) |
View |
| 2018-12-03 Exercise |
2018-12-03 7:00 pm |
N/A N/A |
Atara Biotherapeutics Inc. | ATRA | Newell Joe COO |
1,500 | $20.4 | 72,500 (Direct) |
View |
| 2018-12-03 Exercise |
2018-12-03 7:00 pm |
N/A 2024-04-03 |
Atara Biotherapeutics Inc. | ATRA | Newell Joe COO |
1,500 | $20.4 | 72,500 (Direct) |
View |
| 2018-11-01 Exercise |
2018-11-02 8:15 pm |
N/A N/A |
Atara Biotherapeutics Inc. | ATRA | Newell Joe COO |
1,500 | $20.4 | 74,000 (Direct) |
View |
| 2018-11-01 Exercise |
2018-11-02 8:15 pm |
N/A 2024-04-03 |
Atara Biotherapeutics Inc. | ATRA | Newell Joe COO |
1,500 | $20.4 | 74,000 (Direct) |
View |
| 2018-10-01 Exercise |
2018-10-02 4:25 pm |
N/A N/A |
Atara Biotherapeutics Inc. | ATRA | Newell Joe COO |
1,500 | $20.4 | 75,500 (Direct) |
View |
| 2018-10-01 Exercise |
2018-10-02 4:25 pm |
N/A 2024-04-03 |
Atara Biotherapeutics Inc. | ATRA | Newell Joe COO |
1,500 | $20.4 | 75,500 (Direct) |
View |
| 2018-09-22 Tax Withholding |
2018-09-25 4:17 pm |
N/A N/A |
Atara Biotherapeutics Inc. | ATRA | Ciechanover Isaac E. CEO |
79,328 | $39.85 | 733,285 (Direct) |
View |
| 2018-09-22 Tax Withholding |
2018-09-25 4:17 pm |
N/A N/A |
Atara Biotherapeutics Inc. | ATRA | Soffer Gad EVP & Chief Strategy Officer |
22,158 | $39.85 | 243,966 (Direct) |
View |
| 2018-09-11 Option Award |
2018-09-12 5:57 pm |
N/A 2025-09-10 |
Atara Biotherapeutics Inc. | ATRA | Baynes Roy D. Director |
16,500 | $41.05 | 16,500 (Direct) |
View |
| 2018-09-04 Exercise |
2018-09-05 5:28 pm |
N/A N/A |
Atara Biotherapeutics Inc. | ATRA | Newell Joe COO |
1,500 | $20.4 | 77,000 (Direct) |
View |
| 2018-09-04 Exercise |
2018-09-05 5:28 pm |
N/A 2024-04-03 |
Atara Biotherapeutics Inc. | ATRA | Newell Joe COO |
1,500 | $20.4 | 77,000 (Direct) |
View |
| 2018-08-15 Tax Withholding |
2018-08-16 8:16 pm |
N/A N/A |
Atara Biotherapeutics Inc. | ATRA | Soffer Gad EVP & Chief Strategy Officer |
382 | $35.9 | 266,124 (Direct) |
View |
|
© 2005-2019 SecForm4.Com All rights reserved. Archives: 2019 2018 2017 2016 2015 2014 ... Sun, 17 Feb 2019 22:26:26 -0600 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |